Pharmaceutical Scienceとは 意味・読み方・使い方

・First of all, this vision addresses as changes in the environment surrounding the pharmaceutical industry, trend of research and development in the life science field, especially, that after completion of genome sequencing, post-genome research deals understanding of functions in RNA transcript level and understanding of molecular biological disease structure as important themes and that by reflecting these themes, competition in new drug development gets more serious in the pharmaceutical field such as antibody drugs and molecular targeting drugs.例文帳に追加

・ まず、医薬品産業を取り巻く環境の変化として、生命科学分野の研究開発の動向、特にヒトゲノムの解読を終え、ポストゲノム研究がむしろ RNA 転写レベルでの機能の理解や、分子生物学的な疾病構造の理解などが重要なテーマとなっていること、それを反映して医薬品分野では、抗体医薬や分子標的薬といった新薬開発競争が激化していることを取り上げている。 - 厚生労働省

To provide a simpler and highly accurate method for measuring HbA1c widely usable for industry of a life science field as well as a clinical examination field, a diagnostic medical field, a pharmaceutical field and a health medicine field based on preventive medicine.例文帳に追加

予防医学に基づく臨床検査分野、診断医療分野、製薬分野および保健医学分野をはじめ、生命科学分野の産業に広く利用することができる、よりシンプルで正確性の高いＨｂＡ１ｃの測定方法を構築すること。 - 特許庁

In the 21st century that is said as “century of life science”, the pharmaceutical industry is the one that is expected not only to contribute to improvement of the level of medical treatment for health of citizens but also to largely contribute to economic growth. Because of such industry, competition is accelerated in the world scale.例文帳に追加

・ 「生命科学の世紀」とも言われる 21世紀において、医薬品産業は、国民の保健医療水準の向上に資するだけでなく、経済の発展にも大きく貢献することが期待される産業であるが、このような産業であるからこそ、世界的な規模で競争は激化している。 - 厚生労働省

In the 21st century that is said as “century of life science”, the pharmaceutical industry is the one that is expected not only to contribute to improvement of the level of medical treatment for health of citizens but also to largely contribute to economic growth. Because of such industry, competition is accelerated in the world scale.例文帳に追加

「生命科学の世紀」とも言われる 21世紀において、医薬品産業は、国民の保健医療水準の向上に資するだけでなく、経済の発展にも大きく貢献することが期待される産業であるが、このような産業であるからこそ、世界的な規模で競争は激化している。 - 厚生労働省

For repletion of regulatory science, efforts of the departments and agencies that take charge of the pharmaceutical administration and arrangement of base such as progression of related sciences and repletion of education in the national study and research center and independent administrative agencies for research and development, etc. scientifically supporting the departments and agencies.例文帳に追加

レギュラトリー・サイエンスの充実に向けて、薬事行政を担当する部局の努力とともに、これらを科学的に支える国立試験研究機関、研究開発独立行政法人等における関連諸科学の発展や教育の充実といった基盤の整備が重要である。 - 厚生労働省

Furthermore, the second occasion of communication between the public and private sectors was held on April 26 2007. On this occasion of communication, we decided the “Five-Year Strategy for Creation of Innovative Pharmaceutical Products and Medical Devices” (the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labour and Welfare and the Ministry of Economy, Trade and Industry) composed of intensive infusion of research fund, fostering of venture companies, etc., arrangement of environment for clinical researches and clinical trials, cooperation with Asia, speed-up and quality improvement of regulatory review and proper rewarding of innovation.例文帳に追加

・ さらに、2007 年 4 月 26 日に 2 回目の官民対話を行い、この場で、研究資金の集中投入、ベンチャー企業の育成等、臨床研究・治験環境の整備、アジアとの連携、審査の迅速化・質の向上及びイノベーションの適切な評価からなる「革新的医薬品・医療機器創出のための５か年戦略」（文部科学省・厚生労働省・経済産業省）を決定したところである。 - 厚生労働省

・With regard to the follow-up, since some of the actions plans are the same as those raised the aforementioned 5-year strategy, the “occasion of communication for creation of innovative drugs between the public and private sectors” to be held this year by the Ministry of Health, Labour and Welfare under the participation of the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Economy, Trade and Industry will be utilized, and with regard to the entire action plans, the progress status of the policies will be reported at the “Conference for promotion of pharmaceutical industry policies” as before. (Positioning of this vision)例文帳に追加

・ フォローアップについては、アクションプランの一部が前述の５か年戦略で掲げたものと同じであることから、本年、厚生労働大臣主催により文部科学大臣、経済産業大臣の参画を得て行われることとなった「革新的創薬のための官民対話」の場も活用しつつ、アクションプラン全体については、従来通り「医薬品産業政策の推進に係る懇談会」において施策の進捗状況を報告することとする。 (本ビジョンの位置付け) - 厚生労働省

The above mentioned items were also included as one of the goals in the "5-Year Strategy for the Creation of Innovative Pharmaceuticals and Medical Devices" (April 2007 Cabinet Office, Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare, and the Ministry of Economy, Trade and Industry) so that Japan, which has few natural resources, use its superior research and development abilities to participate in the global development and provision system of innovative pharmaceuticals and medical devices as well as expand the share of innovative pharmaceuticals and medical devices developed in Japan in the global market, thereby allowing the pharmaceutical and medical device industry to drive Japan's growth. Measures for the development of the clinical trial and clinical research environment required to realize this goal were set forth, and this 5-Year Plan plays an important part of these measures.例文帳に追加

上記の事項は、「革新的医薬品・医療機器創出のための５か年戦略」（平成19 年4 月 内閣府・文部科学省・厚生労働省・経済産業省）においても、天然資源の少ない我が国が、優れた研究開発力をもとに、革新的医薬品・医療機器の国際的開発・提供体制へ参加していくとともに、日本で開発される革新的医薬品・ 医療機器の世界市場におけるシェアを拡大することで、医薬品・医療機器産業を日本の成長牽引役へ導くことが目標のひとつとされ、その実現のために臨床研究・治験環境の整備を施策に掲げ、この５カ年計画がその施策の重要な部分を担っていることを示している。 - 厚生労働省